Bone Research Group

Bone Research Group (BRG) is a specialized contract research organization (CRO) and consultancy dedicated to the field of metabolic bone disease. The company provides expert guidance and clinical trial services to pharmaceutical and biotechnology firms developing treatments for conditions such as osteoporosis and rare bone disorders. BRG's core competencies include clinical trial design, site monitoring, and centralized imaging services, specifically for dual-energy X-ray absorptiometry (DXA) and other bone density measurements. Led by prominent bone health expert Dr. Nelson Watts, the group has played a significant role in the clinical development of numerous bone-active therapies, including pivotal trials for several FDA-approved agents.